3D Printing in Healthcare Market Reach $5.84 billion, Globally, by 2030 at 20.1% CAGR dominated by North America during Forecast Period

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, as a result of which these high-dose medicines need not to be swallowed intact. Thus, this form of medication is helpful to patients who often have swallowing difficulties, children, elderly, and those dealing with the complications of stroke, Alzheimers disease, head & neck tumors, and other neurological disorders. The first 3D printed drug to receive approval from the U.S. Food and Drug Administration (FDA) is Spritam (levetiracetam) tablets developed by Aprecia Pharmaceuticals.

3D Printing in Healthcare Market generated $1.03 billion in 2020 and is estimated to reach $5.84 billion by 2030, witnessing a CAGR of 20.1% from 2021 to 2030. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

• Owing to shortage of equipment needed to increase number of patients suffering from Covid-19 infection, the demand for 3D printing in the healthcare sector increased during the pandemic.
• However, manufacturers faced challenges in terms of manufacturing and supply chain due to lockdown measures and unavailability of workers. Investors postponed the plans of investments in new projects.
• Non-elective surgeries were postponed, which in turn, led to reduced demand for 3D printing equipment in the healthcare sector.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/4508

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝟑𝐃 𝐏𝐫𝐢𝐧𝐭𝐞𝐝 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Surge in demand for instantaneous soluble drugs that can disperse easily in the mouth is the major factor that drives the growth of the global 3D printed drugs market. In addition, increase in prevalence of dysphagia, rise in usage of 3D printing technique in the medical & healthcare industries, increase in adoption of personalized drugs, and production of combination medicine boost the market growth.

𝟑𝐃 𝐏𝐫𝐢𝐧𝐭𝐞𝐝 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

Technology Type:

• Fused Deposition Modeling (FDM): Using heated materials to create layers of the drug.
• Powder Bed Printing (PBP): Layer-by-layer printing using powdered drugs and binding agents.
• Direct Ink Writing (DIW): Printing drugs in liquid form using precise deposition techniques.
• Others: As the technology evolves, new 3D printing methods may emerge.

Application:

• Personalized Medicine: Tailoring drug doses and formulations to individual patient needs.
• Print-on-Demand: Printing drugs at the point of care to address immediate needs.
• Complex Dosage Forms: Producing drugs with intricate structures and multiple active ingredients.
• Orphan Drugs: 3D printing can facilitate the production of limited-market drugs for rare diseases.
• Veterinary Medicine: 3D printing drugs for animals and pets.

Drug Type:

• Oral Drugs: Medications intended to be taken by mouth.
• Topical Drugs: Applied to the skin surface for local effects.
• Inhalable Drugs: Administered through the respiratory system.
• Injectable Drugs: Injected into the body for systemic or localized effects.
• Implantable Drugs: Slow-release implants for sustained drug delivery.
• Others: Various drug types can be considered for 3D printing.

End User:

• Hospitals: 3D printing drugs for in-patient and out-patient care.
• Clinics: Smaller medical facilities that utilize 3D printed drugs.
• Research Institutions: Investigating and testing 3D printed pharmaceuticals.
• Others: Any other organizations involved in the 3D printing drug supply chain.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Leading players of the global 3D printing in healthcare market analyzed in the research include 3D Systems Corporation, Formlabs Inc., Exone Company, Materialise NV, General Electric, Organovo Holdings, Inc., Oxferd Performance Materials, Inc., SLM Solutions Group AG, Proto Labs, and Stratasys Ltd.

Key Findings of 3D Printed Drugs Market:

• In North America, the U.S. is anticipated to dominate the market in 2022, whereas rest of North America is projected to grow at the highest CAGR during the forecast period.
• Germany was the major shareholder in the European 3D printed drugs market in 2022.
• Asia-Pacific is expected to register the highest growth rate in future.
• Australia is expected to grow at the highest CAGR in the Asia-Pacific 3D printed drugs market.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/4508

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.